Immunogenicity and safety of coadministration of COVID-19 and influenza vaccination.
View Publication On PubMed
Export 
BiBTeXCoadministration of seasonal quadrivalent influenza and COVID-19 booster vaccination is safe and does not increase vaccine-related side-effects, but may limit anti-SARS-CoV-2 antibody formation https://bit.ly/3uKFUie
SEEK ID: https://ldh.uk-wuerzburg.imise.uni-leipzig.de/publications/7
PubMed ID: 36549716
Trial Projects: CoVacSer
Publication type: Journal
Journal: Eur Respir J
Citation: Eur Respir J. 2023 Jan 6;61(1):2201390. doi: 10.1183/13993003.01390-2022. Print 2023 Jan.
Date Published: 23rd Dec 2022
Registered Mode: by PubMed ID
Export PNG
Download
Submitter
Views: 46
Created: 31st Oct 2024 at 14:04
TagsThis item has not yet been tagged.
AttributionsNone
Related items
https://orcid.org/0009-0000-4383-3107
Josef-Schneider-Straße 2, 97080, Würzburg, Germany
ROR-ID: 03pvr2g57
Trial Projects:
- CoVacSer
- WüRDT
- ARIPro
- Vaccination status and use of complementary medicine in patients with primary immunodeficiency
- Ralstonia pickettii
- Semi-automated infection surveillance in obstetrics and gynecology
Web page: https://www.ukw.de/
The prospective CoVacSer cohort study examines SARS-CoV-2 immunity derived from serial blood samples as well as survey-based quality of life and ability to work in HCWs after COVID-19 vaccination and/or SARS-CoV-2 infection.
Sponsor: University Hospital Würzburg
Public web page: Not specified
Start date: 29th Sep 2021
End date: 31st Dec 2023
